Business Wire

USERTESTING FORTSETTER SITT OPPDRAG OM Å GI MENNESKELIG INNSIKT TIL EUROPEISKE BEDRIFTER MED SIN OVERTAKELSE AV TESTON

Del

UserTesting, den ledende leverandøren av kvalitativ brukertesting og kundeinnsikt, annonserte i dag overtakelsen av Teston, en europeisk leverandør av flerspråklig testing for raske kundetilbakemeldinger. Overtakelsen fremhever UserTesting sin forpliktelse overfor sine europeiske kunder, samt selskapets øvrige kunder rundt omkring i verden som ønsker innsikter i lokale språk, levert enkelt og komfortabelt hjemmefra eller fra kontoret.

Innsamling av kundenes tilbakemeldinger er vesentlig for bedrifter av alle størrelser, uansett hvor de er i verden. Teston bygget platformen sin fra grunnen av med fokus på støtte for flere språk. Med anskaffelsen av Teston, øker UserTesting tilgangen europeiske bedrifter har på brukerinnsikt på eget språk.

Gjennom å kombinere Testons erfaringer og styrker med lokale markeder med UserTestings industriledende teknologi kan vi hjelpe flere bedrifter, store som små, med å samle innsikt fra ulike målgrupper. Slik kan bedriftene ta bedre og raskere avgjørelser.

I 2019 utvidet UserTesting sin virksomhet til Storbritannia – åpnet europeisk hovedkontor i Edinburgh i Skottland, og vokste 300% ved årsskiftet for å imøtekomme etterspørselen fra europeiske bedrifter. UserTesting forstår innvirkningen som kunde-empati har på avgjørelsesprosesser, og forplikter seg til å hjelpe flere bedrifter, i flere land, til å få tilgang til kundenes perspektiv, slik at de enkelt kan skape gode kundeopplevelser.

Det burde være enkelt å samle tilbakemeldinger fra kunder; Teston har laget et brukervennlig produkt og har sterk kompetanse på lokalisering. Dette gir enorm verdi til alt fra voksende oppstartsbedrifter til multinasjonale organisasjoner som ønsker å dra nytte av rask tilgang til brukerinnsikt for å kunne innovere raskere.

“Teston passer godt inn i vår produktportefølje og forsterker vår evne til å gi kundene våre raskest mulig tilgang til menneskelige perspektiver, på et globalt nivå”, uttalte Andy MacMillan, administrerende direktør hos UserTesting. “De har bygget en håndbok for lokalisering som gir oss evnen til å betjene kundene våre som ønsker tilbakemeldinger på europeiske språk”.

Om UserTesting

UserTesting tilbyr løsninger som lar enhver organisasjon levere best mulig kundeopplevelser, driftet av menneskelig innsikt. Med UserTestings Human Insight Platform, kan bedrifter på tvers av alle bransjer foreta nøyaktige og tidsriktige avgjørelser som setter kunden først, på alle nivåer av organisasjonen. Med UserTesting kan produktteam, markedsførere, og spesialister på kundeopplevelse og brukergrensesnitt, med selvtillit skape den rette opplevelsen for alle målgrupper, noe som fører til økt brand-lojalitet og avkastning. UserTesting har mer enn 1 500 abonnerende kunder, inkludert mer enn halvparten av verdens ledende varemerker, og har per dags dato levert menneskelig innsikt til over 35 000 selskaper. UserTesting støttes av Accel, Greenspring og OpenView, og har hovedkvarter i San Francisco, California. For å lære mer, vennligst besøk www.usertesting.com.

Contact information

Mediekontakt:
UserTesting, Inc.
Chris Halcon
415-699-0553
chalcon@usertesting.com

Mediekontakt Storbritannia:
UserTesting, Inc.
Amy Kelly
+44 (0)77 1862 3019
akelly@usertesting.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

British Firm BitePRO Claim Mental Health Care Professionals Are At Risk Of Being Bitten26.2.2020 17:12:00 CETPress release

According to British firm BitePRO, mental health care and special educational needs professionals are at increased risk of being bitten by patients or pupils. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200226005697/en/ Healthcare nurse wearing BitePRO® Bite Resistant Clothing (Photo: Business Wire) Many nurses, care workers and teachers retire on medical grounds. They walk away from the profession they were once extremely passionate about, partly because medical experts have been able to identify that they suffer from real trauma and severe stress. Others, like Minnesota based Special Education Assistant Erin Gonzales are keen to continue and state: “I work at a school where human bites are a daily occurrence, but I work with kids with special needs. But honestly, I wouldn’t trade it for the world.” Oklahoma based Psychiatric Nurse Practitioner Miranda Hagan shares her desire and refuses to give up: “I have permanent sca

BIOCORP: Marketing Partnership on Mallya with iSage Rx in the Field of Digital Diabetes19.2.2020 17:00:00 CETPress release

Regulatory News: BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), a French company specialized in the development and manufacturing of medical devices and smart drug delivery systems, today announced an alliance with US-based iSage Rx, LLC., a digital therapeutics company, focused on insulin dose optimization. In detail, the two companies are committed to integrating their respective technologies to simplify insulin dose capture and optimization. The integration of Mallya (a CE-marked connected device dedicated to insulin pens) into the iSage app (a clinically validated insulin titration platform cleared by the FDA) should enable patients with type 2 diabetes to simplify their insulin management. This will allow patients with diabetes to seamlessly capture, record, and store information about their insulin injections and while receiving automated guidance on how to adjust their insulin dose overtime ("titration"). Ryan Sysko, President and CEO of Amalgam Rx, Inc, said:

New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab)14.2.2020 07:00:00 CETPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced interim data from the Phase 3b STARDUST study. At week 16, 79 percent of patients with moderately to severely active Crohn’s disease (CD) achieved clinical responsea and 67 percent were in clinical remissionb after receiving one ~6 mg/kg intravenous (IV) dose followed by one 90 mg subcutaneous (SC) dose of STELARA® (ustekinumab), open label.1 Intestinal ultrasound (IUS) responses were assessed and were detected as early as week 4.2 Week 16 data (digital oral presentation or DOP 13) and IUS response data (DOP 10) from STARDUST are being presented as part of a digital oral presentation at the 15th Congress of the European Crohn’s & Colitis Organisation (ECCO).1,2 The primary endpoint of the 48-week STARDUST study is comparative endoscopic responsec among adult patients with CD receiving ustekinumab maintenance therapy.3 At week 16, patients who achieved a ≥70 point decrease in Crohn’s Disease Activity Index scored

Edwards Launches New Compact Dry Vacuum Pump With the Highest Pumping Density on the Market13.2.2020 13:07:00 CETPress release

Edwards launch the new nXRi high performance compact dry pump, with lower input power and zero maintenance, bringing real performance improvements and cost benefits across a range of applications. Initial variants will provide pumping speeds of either 60 and 90 m3h-1 , four times more pumping speed than a similar sized dry pump. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200213005447/en/ Edward nXRi Compact Dry Vacuum Pump (Photo: Business Wire) Designed with size in mind, the compact footprint and height allow the Edwards nXRi dry pump to fit easily under a benchtop saving valuable space in the laboratory; and at under 30kg offers a highly mobile vacuum pump for changing work flows and environments. The pump is maintenance free for up to five years, with no tip-seal or oil change, for maximum uptime and reduced maintenance costs. The nXRi's 40% smaller footprint, compared to alternative dry pumps, assures seamless integ

Interactive Brokers Launches Bond Scanner to Help Investors Find the Best Pricing on Wide Range of Fixed Income Products12.2.2020 15:00:00 CETPress release

Interactive Brokers Group, Inc. (Nasdaq: IBKR) today announced it has created a Bond Scanner to help make finding the best prices on bonds easier and more transparent for clients and non-clients alike. “We believe we offer the lowest bond prices available. Investors should visit our Bond Scanner at ibkr.com/bonds, filter for bonds of interest, and then call their broker to compare,” said Steven Sanders, EVP of Marketing and Product Development at Interactive Brokers. “Clients benefit from our aggregation of price quotes from multiple electronic venues and institutional dealers,” he added. “We do not widen spreads nor are there hidden fees or markups. While some companies charge a large, hidden markup, we charge extremely low, transparent commissions. IBKR clients may provide liquidity to bond markets and improve pricing by entering their own pending orders into the book.” In addition to ultra-low, transparent pricing, the company offers a huge selection of fixed income products, includ

ADVA tackles GNSS jamming and spoofing with market’s first intelligent assurance solution11.2.2020 08:00:00 CETPress release

ADVA (FSE: ADV) today launched the industry’s first centralized GNSS monitoring and assurance tool. Using artificial intelligence (AI) and machine learning (ML) for comprehensive predictive maintenance, it addresses the key concerns of GNSS users around the globe. The new customer-owned tool enables users to collect and analyze huge amounts of information from across the network to remotely identify issues and protect networks from GNSS vulnerabilities, including jamming and spoofing attacks. It also helps to identify GNSS obstruction issues, detect blind/poor spots that appear over time and enable optimal antenna positioning. Built into ADVA’s Ensemble Controller network management suite with Sync Director, the solution enables customers to detect potential problems in advance, maintain the highest quality of network synchronization and significantly reduce opex. By complementing today’s limited distributed approach to GNSS assurance with a centralized-global system, it offers a major